VanEck Vectors Video Gaming & eSports ETF ESPO 深 滬
已收盤 02-06 16:00:00 美东时间
94.87
+1.580
+1.69%
華盛通- 最 高95.07
- 今 開94.18
- 成交量 3.47万股
- 最 低 93.74
- 昨 收 93.29
- 總市值 3.04亿
- 52周最高 121.697
- 市盈率 靜 --
- 換手率 1.09%
- 52周最低 76.621
- 委 比 -7.76%
- 總股本 320.00万
- 歷史最高 121.697
- 量 比 0.46
- 振 幅 1.43%
- 歷史最低 20.8301
- 每 手 1
- 風險率 10.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Glencore Says Rio's Bid Not In Best Interests Of Shareholders
BRIEF-Glencore Says Rio's Bid Not In Best Interests Of Shareholders Feb 5 (Reuters) - Glencore PLC GLEN.L : GLENCORE PLC - RESPONSE TO RULE 2.8 ANNOUNCEMENT FROM RIO TINTO GLENCORE - RIO TINTO WILL NOT MAKE OFFER FOR GLENCORE GLENCORE - CONCLUDED THAT PROPOSED ACQUISITION ON THESE TERMS IS NOT IN B
02-05 23:33
UPDATE 3-Thomson Reuters posts fourth-quarter revenue increase, shares rise
UPDATE 3-Thomson Reuters posts fourth-quarter revenue increase, shares rise Thomson Reuters forecasts 2026 revenue growth of 7.5% to 8% AI investments yield tangible benefits, says CEO Hasker Generative AI 28% of Thomson Reuters contract value, says CFO Adds opening stock move in paragraph 4 By Kenn
02-05 20:19
BRIEF-Slb Awarded Integrated Development Contract For Mutriba Field In Kuwait
BRIEF-Slb Awarded Integrated Development Contract For Mutriba Field In Kuwait Feb 3 (Reuters) - Slb NV SLB.N : SLB AWARDED INTEGRATED DEVELOPMENT CONTRACT FOR MUTRIBA FIELD IN KUWAIT SLB AWARDED INTEGRATED DEVELOPMENT CONTRACT FOR MUTRIBA FIELD IN KUWAIT SLB: ANNOUNCED THAT KUWAIT OIL COMPANY HAS AW
02-03 22:08
BRIEF-MPLX LP Reports Q4 Results
BRIEF-MPLX LP Reports Q4 Results Feb 3 (Reuters) - MPLX LP MPLX.N : MPLX Q4 NET INCOME USD 1,193 MILLION MPLX Q4 PRETAX PROFIT USD 1,206 MILLION MPLX Q4 INCOME FROM OPERATIONS USD 1,483 MILLION MPLX Q4 OPERATING EXPENSES USD 419 MILLION MPLX Q4 ADJUSTED EBITDA USD 1,804 MILLION VERSUS. IBES ESTIMATE
02-03 21:19
BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech
BRIEF-Sanegenebio Announces Rnai Global Licensing Collaboration With Genentech Feb 2 (Reuters) - SANEGENEBIO ANNOUNCES RNAI GLOBAL LICENSING COLLABORATION WITH GENENTECH SANEGENEBIO-WILL RECEIVE UPFRONT PAYMENT OF $200 MILLION, WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT, COMMERCIALIZATION MILESTONE PAY
02-02 21:03
Med crude-Urals diffs stable as February cargoes clear slowly
Med crude-Urals diffs stable as February cargoes clear slowly MOSCOW, Jan 29 (Reuters) - Urals crude differentials to dated Brent were stable on Thursday in quiet trade while February cargoes were slow to clear, traders said. India is expected to increase buying of February Urals compared to January
01-30 00:25
BRIEF-Meet The Future Of Autonomous Wildfire Response Xprize Wildfire Announces Finalist Teams Advancing In $11M Competition
BRIEF-Meet The Future Of Autonomous Wildfire Response Xprize Wildfire Announces Finalist Teams Advancing In $11M Competition Jan 29 (Reuters) - PG&E Corp PCG.N : MEET THE FUTURE OF AUTONOMOUS WILDFIRE RESPONSE: XPRIZE WILDFIRE ANNOUNCES FINALIST TEAMS ADVANCING IN $11M COMPETITION Source text: ID:nP
01-29 20:13
BRIEF-Guess?, And Interparfums Extend Their Fragrance Partnership Through 2048
BRIEF-Guess?, And Interparfums Extend Their Fragrance Partnership Through 2048 Jan 26 (Reuters) - Interparfums Inc IPAR.O : GUESS?, INC. AND INTERPARFUMS, INC. EXTEND THEIR FRAGRANCE PARTNERSHIP THROUGH 2048 INTERPARFUMS INC - TO ASSUME FULL GLOBAL RESPONSIBILITY FOR GUESS FRAGRANCES UNTIL DECEMBER
01-27 05:36
BRIEF-Wrap’s Non-Lethal Response Launches “Arrest-in-Control” Training Unit in Collaboration with STORM Training Group
BRIEF-Wrap’s Non-Lethal Response Launches “Arrest-in-Control” Training Unit in Collaboration with STORM Training Group Jan 26 (Reuters) - Wrap Technologies Inc WRAP.O : WRAP’S NON-LETHAL RESPONSE LAUNCHES “ARREST-IN-CONTROL” TRAINING UNIT IN COLLABORATION WITH STORM TRAINING GROUP Source text: ID:nG
01-26 20:34
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy
BRIEF-Janux Therapeutics, Bristol Myers Squibb Sign Exclusive Global License To Develop Tumor-Activated Solid Tumor Therapy Jan 22 (Reuters) - Janux Therapeutics Inc JANX.O : JANUX THERAPEUTICS ANNOUNCES COLLABORATION AND EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH BRISTOL MYERS SQUIBB TO DEVELOP A N
01-22 20:11
